New Delhi: A man in Lucknow reportedly filed an official complaint against Serum Institute of India (SII) CEO Adar Poonawalla and others, alleging that despite taking a dose of Covishield, he still did not develop antibodies.
The above-mentioned complaint has been filed at Aashiana police station in Lucknow, according to IndiaToday reports. Other than Poonawalla, names of DCGA director, Joint Secretary of Health Ministry Luv Agarwal, ICMR director Balaram Bhargava, National Health Mission director Aparna Upadhyay, are among others in the complaint.
As per reports, the complainant, Pratap Chandra, said in his complaint that he received the first jab of SII’s COVID-19 vaccine Covishield on April 8. Chandra also added that he was set to receive the second jab after 28 days. However, on the said day, Chandra reportedly was told that the date for the second vaccine jab had been moved back by six weeks.
Later, the central government officially revised the time gap between the two doses to 12 weeks.
The man also added that he was not feeling too well after receiving the first jab of Covishield. Citing ICMR director general Balram Bhargav’s quotes in media where he had said “good levels of antibodies are produced in the body after the first dose of Covishield”, the Chandra decided to take a Covid Antibody GT test from a government-approved lab.
In his test results, the complainant found that he did not develop any antibodies against coronavirus, instead his platelets went down from 3 lakh to 1.5 lakh.
Chandra alleged that after taking the vaccine he has become more prone to the virus as his platelet count has been reduced by half.
India’s COVID-19 vaccination tally
India has so far administered more than 21.3 crore doses of the coronavirus vaccine, the data from the Ministry of Health and Family Welfare showed on Monday. A total of 21,31,54,129 doses were given till 7 am on May 31, as per the data. Out of these, 10,18,076 doses were administered in the last 24 hours.